Awakn Life Sciences Corp. has announced the success of phase one of its new chemical entity development program to strengthen Awakn’s pipeline for the treatment of a broad range of both substance and behavioral addictions.
Category Press Release
Awakn Life Sciences Corp. has announced the success of phase one of its new chemical entity development program to strengthen Awakn’s pipeline for the treatment of a broad range of both substance and behavioral addictions.